Experiential avoidance in the context of obsessions: Development and validation of the Acceptance and Action Questionnaire for Obsessions and Compulsions

Jacoby, Ryan J.; Abramowitz, Jonathan S.; Buchholz, Jennifer L.; Reuman, Lillian; Blakey, Shannon M.

doi:10.1016/j.jocrd.2018.07.003

Cited by 30 publications

(35 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Experiential avoidance was assessed using the Acceptance and Action Questionnaire for Obsessions and Compulsions adapted to the COVID-19 pandemic (AAQ-OCD-COVID, Jelinek, Göritz et al, 2021 ), which is based on the AAQ-OCD ( Jacoby, Abramowitz, Buchholz, Reuman, & Blakey, 2018 ). In the AAQ-OCD-COVID, participants’ experiential avoidance of obsessions and compulsions related to the COVID-19 pandemic is assessed by 13 items (example: “My intrusive thoughts related to the COVID-19 pandemic determine the actions that I take”), which are rated on a 7-point Likert scale ranging from 1 ( never true ) to 7 ( always true ).…”

Section: Methodsmentioning

confidence: 99%

When a nightmare comes true: Change in obsessive-compulsive disorder over the first months of the COVID-19 pandemic

Jelinek

Voderholzer

Moritz

et al. 2021

Journal of Anxiety Disorders

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

When a nightmare comes true: Change in obsessive-compulsive disorder over the first months of the COVID-19 pandemic

Jelinek

Voderholzer

Moritz

et al. 2021

Journal of Anxiety Disorders

View full text Add to dashboard Cite

“…At the same time, the studies validating the AAQ-II have been criticized on methodological grounds (McAndrews, Richardson, & Stopa, 2018) and the construct validity of the AAQ-II is discussed as being insufficient (Gámez, Chmielewski, Kotov, Ruggero, & Watson, 2011;Tyndall et al, 2018;Wolgast, 2014). Even though PF and ACT are transdiagnostic approaches (Benoy, Bader, & Schumann, 2015), some authors consider the AAQ-II not being specific enough for certain clinical subgroups and diagnosis-specific versions, such as the AAQ-OC for obsessions and compulsions, have been developed (Jacoby, Abramowitz, Buchholz, Reuman, & Blakey, 2018). In addition, the growing number of alternatives measures for PF, such as the Multidimensional Experiential Avoidance Questionnaire (MEAQ) (Gámez et al, 2011), the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT) (Francis, Dawson, & Golijani-Moghaddam, 2016) or the Open and Engaged State Questionnaire (OESQ) underlines the importance of examining how variations of operationalizations perform in different contexts.…”

Section: Introductionmentioning

confidence: 99%

Treatment sensitivity: Its importance in the measurement of psychological flexibility

Benoy

Knitter

Schumann

et al. 2019

Journal of Contextual Behavioral Science

View full text Add to dashboard Cite

Background: Psychological flexibility (PF) is a central construct in Acceptance and Commitment Therapy (ACT). Many studies have operationalized PF using the self-report Acceptance and Actions Questionnaire (AAQ-II). Information on the treatment sensitivity of self-report assessments of PF is lacking, however. We investigated differences in the treatment sensitivity of the AAQ-II compared to other measures of PF across various samples.Methods: Using three different clinical samples (N=164), we compared the pretreatmentposttreatment change scores of the AAQ-II to those of three alternative self-report questionnaires measuring PF in a within-subject design. Sensitivity to change was assessed with effect sizes and Reliable Change Index (RC).Results: Without exception, effect sizes and rates of clinically significant change were larger in all three alternative questionnaires and across three populations compared to the standard formulation of the AAQ-II. Conclusions:The results of the present study show greater treatment sensitivity of three alternative questionnaires measuring PF compared to the AAQ-II. The results suggest that treatment effects concerning PF may have been underestimated depending on the wording and measure used. Implications for research on PF and ACT processes and outcomes are discussed.

show abstract

“…Some studies have shown that the lack of psychological flexibility is related to the severity of OCD symptoms ( 3 ). After 4 weeks of treatment, the prognosis of mental health is closely related to psychological flexibility ( 35 , 36 ). Our study shows that ACT slowly improves symptoms in patients with OCD; however, they can show lasting improvement in the later stage as patients persist in training.…”

Section: Discussionmentioning

confidence: 99%

Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive–Compulsive Disorder

Zou

Yuan

et al. 2022

Front. Psychiatry

View full text Add to dashboard Cite

Objective: This study aims to explore the difference of clinical efficacy and psychological flexibility of sertraline hydrochloride combined with acceptance and commitment therapy (ACT) or repeated transcranial magnetic stimulation (rTMS) in patients with obsessive–compulsive disorder (OCD).Materials and Methods: Sixty-three inpatients diagnosed with OCD were randomly divided into ACT group (N = 32) and rTMS group (N = 31), both of which were combined with sertraline hydrochloride. The following assessments were completed by the Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Yale–Brown Obsessive Compulsive Scale (Y-BOCS), Symptom Checklist 90 (SCL-90), Acceptance and Action Questionnaire (AAQ-II), and Cognitive Fusion Questionnaire (CFQ) during pretreatment, 4 weeks posttreatment, and 8-week follow-up.Results: After treatment: (1) the SCL-90 score of two groups significantly decreased from pretreatment to 8-week follow-up (P < 0.01 and P < 0.001); (2) The HAMA, HAMD, and Y-BOCS scores of the two groups significantly decreased from pretreatment to 8-week follow-up (P < 0.001 and P < 0.05); (3) No statistically significant difference of the SCL-90, HAMA, HAMD and Y-BOCS between two groups; (4) The AAQ-II and CFQ scores of the ACT group significantly decreased from 4 weeks posttreatment to 8-week follow-up (P < 0.01). However, no statistically significant difference was observed in the rTMS group (P > 0.05).Conclusions: Overall, our study suggested that sertraline hydrochloride combined with ACT or rTMS can improve the obsessive–compulsive symptoms, anxiety, and depression and has equivalent efficacy. Moreover, ACT can more effectively and durably improve the psychological flexibility of patients compared with rTMS.

show abstract

Experiential avoidance in the context of obsessions: Development and validation of the Acceptance and Action Questionnaire for Obsessions and Compulsions

Cited by 30 publications

References 52 publications

When a nightmare comes true: Change in obsessive-compulsive disorder over the first months of the COVID-19 pandemic

When a nightmare comes true: Change in obsessive-compulsive disorder over the first months of the COVID-19 pandemic

Treatment sensitivity: Its importance in the measurement of psychological flexibility

Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive–Compulsive Disorder

Contact Info

Product

Resources

About